{"id":"sertraline-fluvoxamine","safety":{"commonSideEffects":[{"rate":"15-25","effect":"Nausea"},{"rate":"15-20","effect":"Headache"},{"rate":"10-20","effect":"Sexual dysfunction"},{"rate":"10-15","effect":"Insomnia"},{"rate":"10-15","effect":"Diarrhea"},{"rate":"5-10","effect":"Tremor"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sertraline and fluvoxamine are both SSRIs that work by inhibiting the serotonin transporter (SERT), preventing the reuptake of serotonin from the synaptic cleft back into presynaptic neurons. This increases serotonin availability at the synapse, enhancing serotonergic neurotransmission. The combination formulation may be used to optimize therapeutic efficacy, though dual SSRI therapy is not standard clinical practice.","oneSentence":"This is a combination of two selective serotonin reuptake inhibitors (SSRIs) that increase synaptic serotonin by blocking its reuptake at the presynaptic membrane.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:07:40.868Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Depression"},{"name":"Anxiety disorders"},{"name":"Obsessive-compulsive disorder"}]},"trialDetails":[{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT05528224","phase":"NA","title":"Effect of SC-ICBT for Adults With OCD：A Three-Arm Randomized Controlled Trial","status":"TERMINATED","sponsor":"Shanghai Mental Health Center","startDate":"2022-09-01","conditions":"Obsessive-Compulsive Disorder","enrollment":46},{"nctId":"NCT06659094","phase":"NA","title":"Reducing Maximal Support in OCD: Efficacy of Stepped-Care Online CBT","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2023-08-21","conditions":"Obsessive Compulsive Disorder (OCD)","enrollment":95},{"nctId":"NCT06942494","phase":"NA","title":"Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-04-30","conditions":"Obsessive - Compulsive Disorder","enrollment":88},{"nctId":"NCT03222570","phase":"PHASE2","title":"An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2018-02-26","conditions":"Depressive Disorder","enrollment":90},{"nctId":"NCT07025590","phase":"NA","title":"Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2025-04-22","conditions":"Cardiovascular Diseases (CVD), Depression Anxiety Disorder","enrollment":106},{"nctId":"NCT04539951","phase":"PHASE2","title":"Pragmatic Trial of Obsessive-compulsive Disorder","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2020-09-22","conditions":"Obsessive-Compulsive Disorder","enrollment":1600},{"nctId":"NCT03321526","phase":"PHASE2","title":"A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-12-12","conditions":"Depressive Disorder, Major","enrollment":107},{"nctId":"NCT02431845","phase":"NA","title":"Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder","status":"RECRUITING","sponsor":"Severance Hospital","startDate":"2013-01-01","conditions":"Obsessive-Compulsive Disorder","enrollment":200},{"nctId":"NCT05588102","phase":"NA","title":"Electronic Training of Elderly Depression With Cognitive Impairment","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2021-05-18","conditions":"Geriatric Depression, Cognitive Impairment","enrollment":128},{"nctId":"NCT06358014","phase":"NA","title":"Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen","status":"RECRUITING","sponsor":"Xiao Wang","startDate":"2023-05-12","conditions":"Postmenopausal Depression, Estrogen","enrollment":40},{"nctId":"NCT06337539","phase":"","title":"Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants","status":"NOT_YET_RECRUITING","sponsor":"Germans Trias i Pujol Hospital","startDate":"2024-04-01","conditions":"Depression, Inflammation, Antidepressants","enrollment":50},{"nctId":"NCT02893371","phase":"","title":"Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2016-09","conditions":"Bipolar Disorder","enrollment":1037352},{"nctId":"NCT03993535","phase":"PHASE4","title":"Predicting Treatment Response in Patients With OCD","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2018-10-10","conditions":"Obsessive-Compulsive Disorder","enrollment":250},{"nctId":"NCT05889234","phase":"","title":"Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2023-11-06","conditions":"Major Depressive Disorder, Magnetic Resonance Imaging, Electroconvulsive Therapy","enrollment":180},{"nctId":"NCT05850572","phase":"NA","title":"A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2023-07","conditions":"Depression","enrollment":100},{"nctId":"NCT03779789","phase":"PHASE4","title":"Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment","status":"COMPLETED","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2019-02-01","conditions":"Major Depressive Disorder","enrollment":362},{"nctId":"NCT05737511","phase":"PHASE4","title":"Efficacy of Hydroxyzine for Patients With Panic Disorder","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2023-12-30","conditions":"Panic Disorder","enrollment":80},{"nctId":"NCT02022709","phase":"PHASE4","title":"Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2014-01","conditions":"Obsessive-Compulsive Disorder, Anxiety Disorders, Mental Disorders","enrollment":78},{"nctId":"NCT04923321","phase":"","title":"Taste Supra-thresholds Among a Sample of Depressed Egyptian Adult Under Anti-depressants Therapy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-02-22","conditions":"Taste Disorders","enrollment":30},{"nctId":"NCT05148169","phase":"PHASE4","title":"A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2020-01-01","conditions":"Major Depressive Disorder","enrollment":150},{"nctId":"NCT04963257","phase":"PHASE4","title":"Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-01-01","conditions":"OCD","enrollment":400},{"nctId":"NCT02655354","phase":"NA","title":"A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity","status":"COMPLETED","sponsor":"University of Washington","startDate":"2015-10","conditions":"Posttraumatic Stress Disorder, Depression, Alcohol-Related Disorders","enrollment":635},{"nctId":"NCT04923425","phase":"","title":"Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-02-22","conditions":"Taste Disorders","enrollment":30},{"nctId":"NCT03599011","phase":"","title":"Gustatory Dysfunction Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-02-22","conditions":"Taste Disorders","enrollment":30},{"nctId":"NCT02285699","phase":"NA","title":"The Gut Microbiota in Obsessive-Compulsive Disorder","status":"COMPLETED","sponsor":"McMaster University","startDate":"2014-11-01","conditions":"Obsessive-Compulsive Disorder","enrollment":43},{"nctId":"NCT02739061","phase":"NA","title":"The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2014-06-12","conditions":"Obsessive-Compulsive Disorder","enrollment":142},{"nctId":"NCT03179839","phase":"NA","title":"The Study of Mindfulness Based Cognitive Therapy and Obsessive-Compulsive Disorder","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2017-01-20","conditions":"Obsessive-Compulsive Disorder","enrollment":123},{"nctId":"NCT03558256","phase":"NA","title":"The Study of Mindfulness-based Cognitive Therapy and Major Depressive Disorder","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2016-05-16","conditions":"Major Depressive Disorder","enrollment":105},{"nctId":"NCT02374567","phase":"PHASE3","title":"Pharmacovigilance in Gerontopsychiatric Patients","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2015-01","conditions":"Dementia, Depression, Schizophrenia","enrollment":407},{"nctId":"NCT01944657","phase":"NA","title":"Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study","status":"WITHDRAWN","sponsor":"Sheppard Pratt Health System","startDate":"2013-09","conditions":"1. Major Depressive Disorder","enrollment":""},{"nctId":"NCT02191358","phase":"","title":"YouScript IMPACT Registry","status":"COMPLETED","sponsor":"Genelex Corporation","startDate":"2014-10","conditions":"Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation","enrollment":800},{"nctId":"NCT02023567","phase":"NA","title":"Objective Diagnostic Markers and Personalized Intervention in MDD Patients","status":"UNKNOWN","sponsor":"Peking University","startDate":"2013-11","conditions":"Depressive Disorder, Major","enrollment":2400},{"nctId":"NCT02320240","phase":"","title":"Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2013-06","conditions":"Depression, Acute Kidney Injury","enrollment":3255526},{"nctId":"NCT01796132","phase":"PHASE4","title":"Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2012-08","conditions":"Depressive Disorder, Lactation","enrollment":500},{"nctId":"NCT01460212","phase":"PHASE4","title":"Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder","status":"UNKNOWN","sponsor":"Nanjing Medical University","startDate":"2011-12","conditions":"Major Depressive Disorder","enrollment":80},{"nctId":"NCT00074815","phase":"PHASE3","title":"Treatment of Obsessive Compulsive Disorder in Children","status":"COMPLETED","sponsor":"Duke University","startDate":"2003-09","conditions":"Obsessive-Compulsive Disorder","enrollment":124},{"nctId":"NCT01896349","phase":"NA","title":"Interpersonal Psychotherapy for Treatment Resistant Depression","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2013-04","conditions":"Treatment Resistant Depression","enrollment":74},{"nctId":"NCT01831440","phase":"NA","title":"Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging","status":"UNKNOWN","sponsor":"Nanjing Medical University","startDate":"2011-01","conditions":"Depressive Disorder","enrollment":200},{"nctId":"NCT01764867","phase":"PHASE4","title":"Algorithm Guided Treatment Strategies for Major Depressive Disorder","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2012-06","conditions":"Major Depressive Disorder","enrollment":1080},{"nctId":"NCT00704860","phase":"PHASE4","title":"Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism","status":"COMPLETED","sponsor":"University of Ottawa","startDate":"2005-02","conditions":"Major Depression","enrollment":27},{"nctId":"NCT00157547","phase":"PHASE4","title":"Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2003-04","conditions":"Major Depressive Disorder","enrollment":95},{"nctId":"NCT00655174","phase":"PHASE3","title":"Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"1999-06","conditions":"Autism","enrollment":108}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":678,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["fluvoxamine"],"phase":"marketed","status":"active","brandName":"sertraline fluvoxamine","genericName":"sertraline fluvoxamine","companyName":"Second Affiliated Hospital, School of Medicine, Zhejiang University","companyId":"second-affiliated-hospital-school-of-medicine-zhejiang-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sertraline is a small molecule used as a selective serotonin reuptake inhibitor (SSRI) in the treatment of conditions such as major depressive disorder. It is also studied in other conditions including taste disorders and geriatric depression, as well as in lactating women and their breastfed infants.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}